Learning Objectives:

1.  Recognize a higher mortality risk conferred by a diagnosis of diabetic autonomic neuropathy (DAN).

2.  Appraise the role of a structured documentation toolkit in finding mortality risk factors in DAN.

3.  Define and implement future best practice alerts in DAN in order to reduce mortality.

Session date: 
04/12/2022 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Alexandru Barboi, MD